Open prospective study on oxcarbazepine in epilepsy in children: A preliminary report

Seizure

Volumn 15, Issue 5, 2006, Pages 292-298

  Franzoni, E ^a   Garone, C ^a   Sarajlija, J ^a   Gualandi, S ^a   Malaspina, E ^a   Cecconi, I ^a   Moscano, F C ^a   Marchiani, V ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Children; Efficacy; Epilepsy; Oxcarbazepine; Tolerability

Indexed keywords

DRUG METABOLITE; OXCARBAZEPINE;

ADOLESCENT; ARTICLE; ATAXIA; BENIGN CHILDHOOD EPILEPSY; CLINICAL ARTICLE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; DIPLOPIA; DISEASE CONTROL; DISEASE EXACERBATION; DIZZINESS; DOCUMENTATION; DROWSINESS; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG EFFICACY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROENCEPHALOGRAM; FATIGUE; FOCAL EPILEPSY; FOLLOW UP; GAIT DISORDER; HUMAN; HYPERPHAGIA; HYPONATREMIA; IDIOPATHIC DISEASE; LABORATORY TEST; LONG TERM CARE; MEMORY DISORDER; MONOTHERAPY; MYALGIA; NAUSEA AND VOMITING; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESSNESS; ROLANDIC EPILEPSY; SCHOOL CHILD;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; HUMANS; PROSPECTIVE STUDIES; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 33744531271     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2006.02.017     Document Type: Article

References (32)

1. Bang L., and Goa K. Oxcarbazepine: a review of its use in children with epilepsy. Paediatr Drugs 5 8 (2003) 557-573
2. Schmidt D., and Elger C.E. What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?. Epilepsy Behav 5 5 (2004) 627-635
3. McLean M.J., Schmutz M., Wamil A.W., Olpe H.R., Portet C., and Feldmann K.F. Oxcarbazepine: mechanism of action. Epilepsia 35 (1994) S5-S9
4. Schmutz M., Brugger F., Gentsch C., McLean M.J., and Olpe H.R. Oxcarbazepine: pre-clinical anticonvulsivant profile and putative mechanism of action. Epilepsia 35 (1994) S47-S50
5. Gonzalez-Esquivel D.F., Ortega-Gavilan M., Alcantara-Lopez G., and Jung-Cook H. Plasma level monitoring of oxcarbazepine in epileptic patients. Arch med res 31 (2000) 202-205
6. Beydoun A., Sachdeo R.C., Rosenfeld W.E., et al. Oxcarbazepine monotherapy for partial-onset seizures: a multicenter, double-blind, clinical trial. Neurology 54 12 (2000) 2245-22451
7. Sachdeo R., Beydoun A., Schachter S.C., et al. Oxcarbazepine (Trileptal) as monotherapy in patients with partial seizures. Neurology 57 5 (2001) 864-871
8. Schachter S.C., Vazquez B., Fisher R.S., et al. Oxcarbazepine: double-blind, randomized, placebo-control, monotherapy trial for partial seizures. Neurology 52 4 (1999) 732-737
9. Glauser T.A., Nigro M., Sachdeo R.C., et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 54 12 (2000) 2237-2244
10. Schmidt D., and Sachdeo R. Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav 1 6 (2000) 396-405
11. Beydoun A., Sachdeo R., Kutluay E., McCague K., and D'Souza J. Sustained efficacy and long-term safety of oxcarbazepine: 1-year open-label extension of a study in refractory partial epilepsy. Epilepsia 44 9 (2003) 1160-1165
12. Coppola G. Treatment of partial seizures in childhood: an overview. CNS Drugs 18 3 (2004) 133-156
13. Albani F., Grassi B., Ferrara R., Turrini R., and Baruzzi A. Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. Seizure 13 4 (2004) 254-263
14. ®, Novartis, data on file, Basle, 1998.
15. Ferrendelli J.A. Concerns with antiepileptic drug initiation: safety, tolerability and efficacy. Epilepsia 42 S4 (2001) 28-30
16. Perucca E. Clinical pharmacology and therapeutic use of the new antiepileptic drugs. Fundam Clin Pharmacol 15 6 (2002) 405-417 Review. Erratum in: Fundam Clin Pharmacol
17. Hengel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE task force on classification and terminology. Epilepsia 42 6 (2001) 796-803
18. Commission on classification and terminology of the international against epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30 (1989) 389-399
19. Sachdeo R., Edward K., Hasegawa H., et al. Safety and efficacy of oxcarbazepine 1200 mg/day in patients with recent onset partial epilepsy. Neurology 52 S2 (1999) A391
20. Schmidt D., and Sachdeo R. Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav 1 (2000) 396-405
21. Gelisse P., Genton P., Kuate C., Pesenti A., Baldi-Moulinier A., and Crespelle A. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 45 10 (2004) 1282-1286
22. Chapman K., Holland K., and Erenberg G. Seizure exacerbation associated with oxcarbazepine in idiopathic focal epilepsy of childhood. Neurology 61 7 (2003) 1012-1013
23. Barcs G., Walker E.B., Elger C.E., et al. Oxcarbazepine: placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia 41 12 (2000) 1597-1607
24. Lloyd P., Flesch G., and Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 35 (1994) S10-S13
25. Sallas W.M., Milosavljev S., D'Souza J., and Hossain M. Pharmacokinetic drug interactions in children taking oxcarbazepine. Clin Pharmacol Ther 74 2 (2003) 138-149
26. Pellock J.M. Tricyclic anticonvulsants: safety and adverse effects. Epilepsy Behav 3 (2002) S19-S23
27. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs, I: treatment of new onset epilepsy. Neurology 62 (2004) 1252-1260
28. French J.A., Kanner A.M., Bautista J., et al. Efficacy and tolerability of the new antiepileptic drugs, II: treatment of refractory epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 49 5 (2004) 410-423
29. Ambrosetto G., Rossi P.G., and Tassinari C.A. Predictive factors of seizure frequency and duration of anti-epileptic treatment in rolandic epilepsy: a retrospective study. Brain Dev 9 3 (1987) 300-304
30. Ambrosetto G., and Tassinari C.A. Antiepileptic drug treatment of benign childhood epilepsy with rolandic spikes: is it necessary?. Epilepsia 31 6 (1990) 802-805
31. Ma C.K., and Chan K.Y. Benign childhood epilepsy with centrotemporal spike: a study of 50 Chinese children. Brain Dev 25 6 (2003) 390-395
32. Hamada Y., Okuno T., Hattori H., and Mikawa H. Indication for antiepileptic drug treatment of benign childhood epilepsy with centrotemporal spikes. Brain Dev 16 2 (1994) 159-161